JNTU B.Pharmacy III MEDICINAL CHEMISTRY-III Previous Question Paper (November/December- 2020 - R17)

The β-lactam inhibitors, such as clavulanic acid, sulbactam, and tazobactam, act as mechanism-based suicide inhibitors of β-lactamase enzymes. Their SAR is defined by the following structural requirements:

1. The β-lactam ring: The strained four-membered lactam ring is essential for the acylation of the active site serine residue of the β-lactamase enzyme. Opening of this ring is the primary step in the inhibition mechanism.
2. Stereochemistry: The stereochemistry at the bridgehead carbons is critical. In naturally occurring inhibitors like clavulanic acid, the (5R)-configuration is required for optimal binding and enzyme inactivation.
3. The C-2 substituent: The presence of a side chain at the C-2 position influences the stability and the ability of the molecule to mimic the transition state of the β-lactamase-catalyzed hydrolysis. In clavulanic acid, the (Z)-2-hydroxyethylidene group is vital for the rearrangement that leads to the formation of a reactive imine intermediate.
4. The C-3 substituent: In penicillanic acid sulfones like sulbactam, the sulfone group at the 1-position increases the electrophilicity of the β-lactam carbonyl, facilitating the nucleophilic attack by the enzyme's serine residue.
5. The 1-position heteroatom: The oxygen atom in the oxapenam nucleus of clavulanic acid makes the β-lactam ring more reactive toward nucleophilic attack compared to the sulfur atom found in penams, contributing to its potent inhibitory activity.
6. Absence of C-6 acylamino side chain: Unlike active penicillins, β-lactamase inhibitors lack the C-6 acylamino side chain. This modification prevents the molecule from acting as a substrate for transpeptidase enzymes (reducing antibacterial activity) while allowing it to fit specifically into the active site of β-lactamases.

These structural features allow the inhibitors to bind covalently to the β-lactamase, forming a stable acyl-enzyme complex that prevents the enzyme from degrading co-administered antibiotics.

Tetracyclines are a group of broad-spectrum polyketide antibiotics characterized by a common chemical structure consisting of four linearly fused six-membered rings (a naphthacene core). They exert their antibacterial effect by reversibly binding to the 30S ribosomal subunit of susceptible microorganisms, thereby inhibiting protein synthesis.

They are classified based on their source and duration of action:

• Natural Tetracyclines: Derived from Streptomyces species, e.g., Tetracycline, Oxytetracycline, and Chlortetracycline.
• Semi-synthetic Tetracyclines: Chemically modified derivatives with improved pharmacokinetic profiles, e.g., Doxycycline, Minocycline, and Methacycline.

Tetracyclines are chemically unstable, particularly in aqueous solutions, due to the presence of multiple functional groups. The primary degradation pathways include:

• Acid-catalyzed degradation: In acidic conditions (pH < 2), tetracyclines undergo dehydration at the C-6 position to form anhydrotetracyclines. These compounds are biologically inactive and potentially toxic (Fanconi-like syndrome).
• Base-catalyzed degradation: In alkaline conditions (pH > 8), the molecule undergoes ring cleavage, specifically involving the C-11a and C-12 positions, leading to the formation of isotetracyclines. This process involves the opening of the C-ring.
• Epimerization: In the pH range of 2 to 6, the dimethylamino group at the C-4 position undergoes epimerization to form 4-epitetracyclines. This reaction is reversible and results in a significant loss of antibacterial potency, as the epimer has much lower affinity for the bacterial ribosome.